On modeling and measuring viscoelasticity with dynamic Atomic Force Microscopy

The interaction between a rapidly oscillating atomic force microscope tip and a soft material surface is described using both elastic and viscous forces with a moving surface model. We derive the simplest form of this model, motivating it as a way to capture the impact dynamics of the tip and sample with an interaction consisting of two components: interfacial or surface force, and bulk or volumetric force. Analytic solutions to the piece-wise linear model identify characteristic time constants, providing a physical explanation of the hysteresis observed in the measured dynamic force quadrature curves. Numerical simulation is used to fit the model to experimental data and excellent agreement is found with a variety of different samples. The model parameters form a dimensionless impact-rheology factor, giving a quantitative physical number to characterize a viscoelastic surface that does not depend on the tip shape or cantilever frequency.Comment: 13 pages, 7 figure

Modeling and Measuring Viscoelasticity with Dynamic Atomic Force Microscopy

The interaction between a rapidly oscillating atomic-force-microscope tip and a soft-material surface is described with use of both elastic and viscous forces in a moving-surface model. We present the simplest form of this model, motivating our derivation with the models ability to capture the impact dynamics of the tip and sample with an interaction consisting of two components: interfacial or surface force, and bulk or volumetric force. Analytic solutions to the piecewise linear model identify characteristic time constants, providing a physical explanation for the hysteresis observed in the measured dynamic-force-quadrature curves. Numerical simulation is used to fit the model to experimental data, and excellent agreement is found with a variety of different samples. The model parameters form a dimensionless impact-rheology factor, giving a quantitative physical number to characterize a viscoelastic surface that does not depend on the tip shape or cantilever frequency

Phenotypic cha- racterization of pig genetic resources in the departments of Oueme and Plateau in Benin

L’élevage porcin est très pratiqué au Sud-Bénin et implique une diversité de races ou de populations. L’objectif de l’étude était de caractériser les différents porcs sur le plan morphométrique et phénotypique. Ainsi, les données phéno- typiques ont été collectées sur 149 porcs, dont 14 améliorés, 91 croisés et 44 locaux. Les porcs de type génétique local ont présenté des mesures morpho- logiques significativement inférieures (p < 0,05) à celles des porcs améliorés et des animaux issus des croisements entre les porcs améliorés et les porcs locaux. Les poils des porcs locaux étaient significativement plus courts (p < 0,05) que ceux des porcs améliorés et des croisés. La couleur de la robe a varié d’un type génétique à l’autre. La couleur la plus rencontrée a été le blanc uniforme, suivi du noir uniforme chez tous les types génétiques. Le profil de la tête était plus rectiligne chez les porcs locaux, et plus concave chez les porcs améliorés et chez les croisés. Les oreilles dressées étaient moins observées chez les croisés. Elles étaient orientées vers l’avant chez les porcs améliorés et chez les croisés alors qu’elles étaient dressées et orientées vers l’arrière chez les porcs locaux. La queue en tire-bouchon a été significativement (p < 0,05) plus présente chez les porcs améliorés que chez les porcs croisés, et elle a été plus présente chez ces derniers que chez les porcs locaux. La ligne dorsale droite a été davantage observée chez les porcs locaux et chez les croisés que chez les porcs amélio- rés chez lesquels la ligne était plus creuse. Les porcs croisés ont présenté une grande similarité avec les porcs améliorés

Renormalization of four-quark operators, effective theory, and the role of evanescent operators

We present, in the context of dimensional regularization, a prescription to renormalize Feynman diagrams with an arbitrary number of external fermions. This prescription, which is based on the original t'Hooft-Veltman proposal to keep external particles in four dimensions, is particularly useful to define the 'renormalization' (in the context of effective Lagrangian) of physical four-quark operators without introducing any evanescent operator. The results obtained for $b\rightarrow s$ processes agree with those from the so-called naive prescription, but disagree with the ones with the introduction of evanescent operators in a renormalization group analysis. We also present an explicit two loop calculation of the mixing of the evanescent operators with the physical dimension five operators for the same processes. Particular attention is paid to the unboundedness nature of such mixing and how a formal finite transformation is effected to decouple. The inevitable mass dependence of one of these schemes in the literature is pointed out as the cause for the difference mentioned.Comment: 39 pages plain TeX and 10 Postscript figures available upon request, McGill/ 94-14 and UM-TH-94-2

In vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in Central Ethiopia

<p>Abstract</p> <p>Background</p> <p><it>In vivo </it>efficacy assessments of the first-line treatments for <it>Plasmodium falciparum </it>malaria are essential for ensuring effective case management. In Ethiopia, artemether-lumefantrine (AL) has been the first-line treatment for uncomplicated <it>P. falciparum </it>malaria since 2004.</p> <p>Methods</p> <p>Between October and November 2009, we conducted a 42-day, single arm, open label study of AL for <it>P. falciparum </it>in individuals >6 months of age at two sites in Oromia State, Ethiopia. Eligible patients who had documented <it>P. falciparum </it>mono-infection were enrolled and followed according to the standard 2009 World Health Organization <it>in vivo </it>drug efficacy monitoring protocol. The primary and secondary endpoints were PCR uncorrected and corrected cure rates, as measured by adequate clinical and parasitological response on days 28 and 42, respectively.</p> <p>Results</p> <p>Of 4426 patients tested, 120 with confirmed falciparum malaria were enrolled and treated with AL. Follow-up was completed for 112 patients at day 28 and 104 patients at day 42. There was one late parasitological failure, which was classified as undetermined after genotyping. Uncorrected cure rates at both day 28 and 42 for the per protocol analysis were 99.1% (95% CI 95.1-100.0); corrected cure rates at both day 28 and 42 were 100.0%. Uncorrected cure rates at day 28 and 42 for the intention to treat analysis were 93.3% (95% CI 87.2-97.1) and 86.6% (95% CI 79.1-92.1), respectively, while the corrected cure rates at day 28 and 42 were 94.1% (95% CI 88.2-97.6) and 87.3% (95% CI 79.9-92.7), respectively. Using survival analysis, the unadjusted cure rate was 99.1% and 100.0% adjusted by genotyping for day 28 and 42, respectively. Eight <it>P. falciparum </it>patients (6.7%) presented with <it>Plasmodium vivax </it>infection during follow-up and were excluded from the per protocol analysis. Only one patient had persistent parasitaemia at day 3. No serious adverse events were reported, with cough and nausea/vomiting being the most common adverse events.</p> <p>Conclusions</p> <p>AL remains a highly effective and well-tolerated treatment for uncomplicated falciparum malaria in the study setting after several years of universal access to AL. A high rate of parasitaemia with <it>P. vivax </it>possibly from relapse or new infection was observed.</p> <p>Trial Registration</p> <p><a href="http://www.clinicaltrials.gov/ct2/show/NCT01052584">NCT01052584</a></p

Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa.

BACKGROUND: Tuberculosis (TB) remains a global health threat with 9 million new cases and 1.4 million deaths per year. In order to develop a protective vaccine, we need to define the antigens expressed by Mycobacterium tuberculosis (Mtb), which are relevant to protective immunity in high-endemic areas. METHODS: We analysed responses to 23 Mtb antigens in a total of 1247 subjects with different HIV and TB status across 5 geographically diverse sites in Africa (South Africa, The Gambia, Ethiopia, Malawi and Uganda). We used a 7-day whole blood assay followed by IFN-γ ELISA on the supernatants. Antigens included PPD, ESAT-6 and Ag85B (dominant antigens) together with novel resuscitation-promoting factors (rpf), reactivation proteins, latency (Mtb DosR regulon-encoded) antigens, starvation-induced antigens and secreted antigens. RESULTS: There was variation between sites in responses to the antigens, presumably due to underlying genetic and environmental differences. When results from all sites were combined, HIV- subjects with active TB showed significantly lower responses compared to both TST(-) and TST(+) contacts to latency antigens (Rv0569, Rv1733, Rv1735, Rv1737) and the rpf Rv0867; whilst responses to ESAT-6/CFP-10 fusion protein (EC), PPD, Rv2029, TB10.3, and TB10.4 were significantly higher in TST(+) contacts (LTBI) compared to TB and TST(-) contacts fewer differences were seen in subjects with HIV co-infection, with responses to the mitogen PHA significantly lower in subjects with active TB compared to those with LTBI and no difference with any antigen. CONCLUSIONS: Our multi-site study design for testing novel Mtb antigens revealed promising antigens for future vaccine development. The IFN-γ ELISA is a cheap and useful tool for screening potential antigenicity in subjects with different ethnic backgrounds and across a spectrum of TB and HIV infection states. Analysis of cytokines other than IFN-γ is currently on-going to determine correlates of protection, which may be useful for vaccine efficacy trials